Atosiban and nifedipin for the treatment of preterm labor

International Journal of Gynecology & Obstetrics - Tập 91 - Trang 10-14 - 2005
M. Kashanian1, A.R. Akbarian2, M. Soltanzadeh1
1Iran University of Medical Sciences and Health Services. Department of Obstetrics and Gynecology, Akbar Abadi Teaching Hospital, Tehran, Iran
2Iran University of Medical Sciences and Health Services. Department of Obstetrics and Gynecology, Hazrat Rasool Hospital, Tehran, Iran

Tóm tắt

AbstractObjectiveTo perform a comparison between atosiban (oxytocin antagonist) and nifedipin (calcium channel blocker) for acute treatment of preterm labor and their maternal safety. Methods: A randomized controlled trial study was performed on 80 pregnant women with preterm labor, between 26 and 34 weeks of pregnancy, in Akbar Abadi Teaching Hospital in Tehran, Iran. 40 women (the atosiban group) were compared with another 40 women (the nifedipin group) for the drugs' efficacy in delaying delivery for more than 48 h in order to undergo steroid therapy, and for more than 7 days or more, and also to assess their maternal safety. The duration between the drugs' administration and delivery were compared. The statistical analysis was performed using the Statistical Package for Social Science (SPSS). Results: There was no statistically significant difference between the two groups in the treatment of preterm labor. Atosiban was effective in 82.5% of cases, and nifedipin in 75% of the cases (p = 1.000), for delaying delivery for 48 h. Atosiban was effective in 75% of the cases, and nifedipin in 65% of the cases, for delaying delivery for more than 7 days. The maternal side effects in the atosiban group were 17.5%, and in the nifedipin group they were 40%, which had a statistically significant difference (p = 0.027). The duration between treatment and delivery was 29.03 ± 16.12 days in the atosiban group and 22.85 ± 13.9 days in the nifedipin group with no statistically significant difference (p = 0.79). Conclusion: Atosiban is an effective and safe drug for the acute treatment of preterm labor with minimal side effects, and it can be an option in the treatment of preterm labor, especially in patients with heart disease and multi‐fetal pregnancies.

Tài liệu tham khảo

American College of Obstetricians and Gynecologist preterm labor. Technical Bulletin NO. 206 June 1995. 10.1067/mob.2000.95834 10.2165/00003495-200464040-00003 Goodwin T.M., 1996, Treatment of preterm labor with the oxytocin antagonist atosiban, Am J Perinatol, 13, 2879, 10.1055/s-2007-994312 10.1067/mob.2000.104950 The Worldwide Atosiban versus β‐agonists Study Group, 2001, Effectiveness and safety of the oxytocin antagonist atosiban versus β‐adrenergic in the treatment of preterm labor, BJOG, 108, 133, 10.1111/j.1471-0528.2001.00043.x 10.1067/mob.2000.105816 Goodwin T.M., 1995, The pharmaco kinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions, Am J Obstet Gynecol, 173, 1555 10.1097/00006250-199404000-00024 10.1046/j.0004-8666.2003.00074.x Cunningham F.G., 2001, Williams obstetrics, 689 10.1016/S0029-7844(97)00182-8 Motulsky H., 1995, Intuitive biostatistics, 374 Tintinalli J.E., 2000, Emergency medicine, a comprehensive study guide, 54 Henry J.B., 2001, Clinical diagnosis and management by laboratory methods, 371 Coomarasamy A., 2003, Effectiveness of nifedipin versus atosiban for tocolysis in preterm labor: a meta‐analysis with indirect comparison of randomized trials, BJOG, 110, 1045, 10.1111/j.1471-0528.2003.03071.x 10.1034/j.1600-0412.2001.d01-456.x French–Australian Atosiban Investigator Group, 2001, Treatment of Preterm labor with the Oxytocin antagonist atosiban: a double‐blind, randomized controlled comparison with salbutamol, Eur J Obstet Gynecol Reprod Biol, 98, 177, 10.1016/S0301-2115(01)00331-1 RichterO.N. DornC. Van De VondelP. UlrichU. SchmollingJ.Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy. Arch Gynecol Obstet2004(Jul.) [Electronic publication ahead of print] Lurie S., 2004, Atosiban treatment for uterine hyperactivity during active labor: a pilot study, J Perinat Med, 32, 137 10.1111/j.1471-0528.2004.00095.x
Thông tin
Thông tin xuất bản

International Journal of Gynecology & Obstetrics

Tập 91

10-14

Thông tin tác giả